Variant report
Variant | esv14856 |
---|---|
Chromosome Location | chr4:74942304-74945441 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:74942157..74944634-chr4:74946654..74948863,2 | K562 | blood: | |
2 | chr4:74944433..74947209-chr4:74963133..74965941,3 | K562 | blood: | |
3 | chr4:74934690..74937299-chr4:74941932..74944462,2 | K562 | blood: | |
4 | chr4:74901988..74904846-chr4:74940874..74944131,3 | K562 | blood: | |
5 | chr4:74908077..74910007-chr4:74941278..74943027,2 | K562 | blood: | |
6 | chr4:74934429..74938558-chr4:74940734..74946134,5 | K562 | blood: | |
7 | chr4:74921706..74923653-chr4:74943213..74945462,3 | K562 | blood: | |
8 | chr4:74940510..74942494-chr4:74955142..74957369,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000081041 | chromatin interactions |
ENSG00000163734 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs180953874 | chr4:74942426-74942427 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs554611301 | chr4:74942450-74942451 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs573025574 | chr4:74942482-74942483 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs375667570 | chr4:74942491-74942492 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs145193496 | chr4:74942503-74942504 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs564972803 | chr4:74942557-74942558 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs370173369 | chr4:74942558-74942559 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs577459105 | chr4:74942580-74942581 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs374439366 | chr4:74942586-74942587 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs527674419 | chr4:74942601-74942602 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs114962744 | chr4:74942603-74942604 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs546193091 | chr4:74942643-74942644 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs563044794 | chr4:74942646-74942647 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs530271939 | chr4:74942675-74942676 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs548815398 | chr4:74942690-74942691 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs548781532 | chr4:74942917-74942918 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs185603202 | chr4:74942967-74942968 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs527411032 | chr4:74942989-74942990 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs375074977 | chr4:74943042-74943043 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs369276905 | chr4:74943067-74943068 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs552183198 | chr4:74943111-74943112 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs570499868 | chr4:74943124-74943125 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs531501419 | chr4:74943147-74943148 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs76382855 | chr4:74943189-74943190 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs568281528 | chr4:74943227-74943228 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs552486875 | chr4:74943282-74943283 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs567340670 | chr4:74943316-74943317 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs569185633 | chr4:74943328-74943329 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs553581175 | chr4:74943381-74943382 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs566614086 | chr4:74943412-74943413 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs199498848 | chr4:74943491-74943492 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs534068349 | chr4:74943517-74943518 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs558525601 | chr4:74943564-74943565 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs538456072 | chr4:74943568-74943569 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs113173861 | chr4:74943570-74943571 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs577123025 | chr4:74943611-74943612 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs375898029 | chr4:74943655-74943656 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs556780845 | chr4:74943721-74943722 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs148754725 | chr4:74943729-74943730 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs190531181 | chr4:74943737-74943738 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs142304596 | chr4:74943739-74943740 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs548460452 | chr4:74943769-74943770 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs529206762 | chr4:74943790-74943791 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs528310864 | chr4:74943806-74943807 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs560698850 | chr4:74943829-74943830 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs527369399 | chr4:74943843-74943844 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs181815501 | chr4:74943864-74943865 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs547084507 | chr4:74943895-74943896 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs564027944 | chr4:74943897-74943898 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs115832564 | chr4:74943923-74943924 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20932292 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:74939400-74944800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr4:74939600-74944800 | Weak transcription | Primary hematopoietic stem cells | blood |
3 | chr4:74940000-74944400 | Weak transcription | K562 | blood |
4 | chr4:74940200-74944400 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
5 | chr4:74942600-74943400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
6 | chr4:74943800-74947800 | Weak transcription | Aorta | Aorta |
7 | chr4:74944200-74945000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
8 | chr4:74944200-74952600 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr4:74944400-74945200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
10 | chr4:74944400-74945200 | Enhancers | K562 | blood |
11 | chr4:74944400-74947400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
12 | chr4:74944800-74945200 | Enhancers | Primary hematopoietic stem cells | blood |
13 | chr4:74944800-74945200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr4:74944800-74945200 | Enhancers | Spleen | Spleen |
15 | chr4:74945000-74945400 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
16 | chr4:74945000-74948800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
17 | chr4:74945200-74948600 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
18 | chr4:74945200-74949000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
19 | chr4:74945200-74949600 | Weak transcription | K562 | blood |
20 | chr4:74945400-74946800 | Enhancers | Monocytes-CD14+_RO01746 | blood |